NCT05727761: An ongoing trial by University of Minnesota
This trial is ongoing. It must report results 1 year, 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05727761 |
|---|---|
| Title | Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 1, 2025 |
| Completion date | July 28, 2026 |
| Required reporting date | July 28, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |